Compare Stocks: PHUN, RDCM, ZSQR, and EGAN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EGAN eGain	$5.26 +2.3%	$6.78	$5.02 ▼ $15.95	$141.09M	0.83	214,517 shs	287,333 shs
PHUN Phunware	$2.03 +0.5%	$2.11	$1.56 ▼ $3.13	$41.34M	2.61	72,453 shs	161,583 shs
RDCM Radcom	$9.91 -0.5%	$11.43	$9.40 ▼ $16.74	$165.87M	0.74	140,358 shs	104,536 shs
ZSQR Coeptis Therapeutics	$3.07 -2.8%	$4.66	$2.81 ▼ $21.41	$167.48M	-0.25	338,119 shs	174,958 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EGAN eGain	+2.33%	-9.93%	-27.85%	-29.11%	-33.25%
PHUN Phunware	+0.50%	-2.40%	-3.33%	+5.18%	-21.92%
RDCM Radcom	-0.50%	-1.20%	-3.97%	-22.58%	-28.45%
ZSQR Coeptis Therapeutics	-2.85%	+4.07%	-21.08%	-71.91%	-75.46%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EGAN eGain	$5.26 +2.3%	$6.78	$5.02 ▼ $15.95	$141.09M	0.83	214,517 shs	287,333 shs
PHUN Phunware	$2.03 +0.5%	$2.11	$1.56 ▼ $3.13	$41.34M	2.61	72,453 shs	161,583 shs
RDCM Radcom	$9.91 -0.5%	$11.43	$9.40 ▼ $16.74	$165.87M	0.74	140,358 shs	104,536 shs
ZSQR Coeptis Therapeutics	$3.07 -2.8%	$4.66	$2.81 ▼ $21.41	$167.48M	-0.25	338,119 shs	174,958 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EGAN eGain	+2.33%	-9.93%	-27.85%	-29.11%	-33.25%
PHUN Phunware	+0.50%	-2.40%	-3.33%	+5.18%	-21.92%
RDCM Radcom	-0.50%	-1.20%	-3.97%	-22.58%	-28.45%
ZSQR Coeptis Therapeutics	-2.85%	+4.07%	-21.08%	-71.91%	-75.46%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EGAN eGain	2.00	Hold	$6.50	23.57% Upside
PHUN Phunware	1.50	Reduce	$2.00	-1.48% Downside
RDCM Radcom	2.00	Hold	$14.00	41.27% Upside
ZSQR Coeptis Therapeutics	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest PHUN, RDCM, ZSQR, and EGAN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	RDCM Radcom	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C+) ➝ Hold (C)
9/8/2026	EGAN eGain	B Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/8/2026	EGAN eGain	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$21.00 ➝ $7.00
9/8/2026	EGAN eGain	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$10.50 ➝ $6.00
8/14/2026	ZSQR Coeptis Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E-)
8/12/2026	RDCM Radcom	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/12/2026	RDCM Radcom	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/12/2026	RDCM Radcom	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$18.00 ➝ $14.00
8/7/2026	EGAN eGain	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
7/8/2026	PHUN Phunware	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/24/2026	PHUN Phunware	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EGAN eGain	$91.14M	1.58	$0.23 per share	22.89	$2.95 per share	1.78
PHUN Phunware	$2.75M	15.10	N/A	N/A	$4.77 per share	0.43
RDCM Radcom	$67.59M	2.45	$0.78 per share	12.72	$6.88 per share	1.44
ZSQR Coeptis Therapeutics	$1.36M	119.64	N/A	N/A	$2.63 per share	1.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EGAN eGain	$8.88M	$0.32	16.44	N/A	N/A	9.74%	11.63%	7.12%	11/11/2026 (Estimated)
PHUN Phunware	-$11.40M	-$0.65	N/A	N/A	N/A	-471.72%	-13.79%	-12.37%	11/5/2026 (Estimated)
RDCM Radcom	$11.99M	$0.42	23.60	495.50	N/A	10.47%	6.51%	5.17%	11/11/2026 (Estimated)
ZSQR Coeptis Therapeutics	-$11.92M	-$1.63	N/A	N/A	N/A	-773.72%	-49.45%	-46.88%	N/A

Latest PHUN, RDCM, ZSQR, and EGAN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/3/2026	Q4 2026	EGAN eGain	$0.03	$0.08	+$0.05	$0.05	$21.75 million	$22.15 million
8/13/2026	Q2 2026	ZSQR Coeptis Therapeutics	N/A	-$0.28	N/A	-$0.28	N/A	$1.58 million
8/12/2026	Q2 2026	RDCM Radcom	$0.24	-$0.09	-$0.33	-$0.18	$15.57 million	$11.76 million
8/6/2026	Q2 2026	PHUN Phunware	-$0.14	-$0.26	-$0.12	-$0.26	$0.80 million	$0.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
EGAN eGain	N/A	N/A	N/A	N/A	N/A
PHUN Phunware	N/A	N/A	N/A	N/A	N/A
RDCM Radcom	N/A	N/A	N/A	N/A	N/A
ZSQR Coeptis Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EGAN eGain	N/A	2.15	2.15
PHUN Phunware	N/A	19.84	19.84
RDCM Radcom	N/A	6.20	6.17
ZSQR Coeptis Therapeutics	N/A	7.66	7.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EGAN eGain	53.94%
PHUN Phunware	7.57%
RDCM Radcom	48.32%
ZSQR Coeptis Therapeutics	13.88%

Insider Ownership

Company	Insider Ownership
EGAN eGain	38.70%
PHUN Phunware	0.20%
RDCM Radcom	69.00%
ZSQR Coeptis Therapeutics	24.25%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EGAN eGain	690	27.45 million	16.83 million	Optionable
PHUN Phunware	120	20.46 million	20.42 million	Optionable
RDCM Radcom	280	16.74 million	5.19 million	Not Optionable
ZSQR Coeptis Therapeutics	2	53.00 million	40.15 million	Not Optionable

PHUN, RDCM, ZSQR, and EGAN Headlines

Recent News About These Companies

Coeptis Therapeutics (NASDAQ:ZSQR) Shares Down 2.9% - What's Next?

September 10 at 2:00 AM | americanbankingnews.com

Coeptis Therapeutics (NASDAQ:ZSQR) Shares Down 2.9% - Time to Sell?

September 10 at 1:59 AM | marketbeat.com

Z Squared Acquires Energized Arkansas Campus to Advance AI Infrastructure Strategy

September 9 at 7:00 AM | prnewswire.com

Z Squared CEO to Shareholders: "The Scarcest Thing in AI is Not Chips. It is Power.

August 14, 2026 | prnewswire.com

Coeptis Therapeutics (NASDAQ:ZSQR) Issues Quarterly Earnings Results

August 13, 2026 | marketbeat.com

Z Squared Inc. Signs Definitive Agreement to Acquire 100% of Paradox Data and Its Union County Campus

August 3, 2026 | prnewswire.com

Z Squared Inc. Terminates At-The-Market Sales Agreement and Committed Equity Forward Purchase Agreement

July 17, 2026 | prnewswire.com

Z Squared Inc. Provides Capital Structure Update

July 15, 2026 | prnewswire.com

Z Squared Inc. Appoints Jeffrey Harris as Chief Technology Officer

June 30, 2026 | prnewswire.com

Z Squared Raises Approximately $15.3 Million in Non-Debt Capital to Advance AI Infrastructure Strategy

June 29, 2026 | prnewswire.com

Russell Indexes Add Z Squared Inc. to Russell 2000® and Russell 3000®

June 29, 2026 | prnewswire.com

Z Squared, Inc. to Acquire Majority Interest in Paradox Data and Its Union County Campus, a Next-Generation Data Center Development Targeting Up to 150 MW of Firm Power

June 25, 2026 | prnewswire.com

Z Squared to Participate in Maxim Group's AI Data Center Summit

June 9, 2026 | prnewswire.com

Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement to Support AI Infrastructure Buildout

June 4, 2026 | prnewswire.com

Z Squared, Inc. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes

May 27, 2026 | prnewswire.com

Vanderbilt Report: Z Squared Locks In Zero-Cash, Zero-Debt Path to 42 MW of AI-Ready Power

May 26, 2026 | globenewswire.com

Z Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference Workloads

May 19, 2026 | prnewswire.com

Z Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory Board

May 4, 2026 | prnewswire.com

Z Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MW

April 29, 2026 | prnewswire.com

Z Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global Market

April 28, 2026 | prnewswire.com

Coeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing Application

April 27, 2026 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHUN, RDCM, ZSQR, and EGAN Company Descriptions

eGain NASDAQ:EGAN

$5.26 +0.12 (+2.33%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$5.20 -0.06 (-1.14%)

As of 09/11/2026 07:30 PM Eastern

eGain Corporation develops, licenses, implements, and supports customer service infrastructure software solutions in North America, Europe, the Middle East, Africa, and the Asia Pacific. It provides eGain Knowledge Hub, which helps businesses to centralize knowledge, policies, procedures, situational expertise, best-practices, while delivering guided, and personalized solutions to customers and agents; eGain Conversation Hub for digital-first, omnichannel interaction management within a modern, purpose-built desktop; and eGain Analytics Hub enables clients to measure, manage, and optimize omnichannel service operations and knowledge. The company also offers subscription services that provides customers with access to its software on a cloud-based platform; and professional services, such as consulting and implementation, training, and managed services. It serves customers in various industry sectors, including the financial services, telecommunications, retail, government, healthcare, and utilities. The company was incorporated in 1997 and is headquartered in Sunnyvale, California.

Phunware NASDAQ:PHUN

$2.03 +0.01 (+0.50%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$2.03 +0.00 (+0.20%)

As of 09/11/2026 07:56 PM Eastern

Phunware, Inc., together with its subsidiaries, provides integrated software platform that equips companies with the products, solutions, and services to engage, manage, and monetize their mobile application portfolios in the United States and internationally. The company's products and services include mobile software and application transaction solutions comprise integration of software development kit (SDK) licenses, which consists of analytics that offers data related to application use and engagement; content management that allows application administrators to create and manage app content in a cloud-based portal; alerts, notifications, and messaging, which enables brands to send messages; marketing automation that enables location-triggered messages and workflow; advertising; and location-based services, such as mapping, navigation, wayfinding, workflow, asset management, and policy enforcement. It is also involved in the integration of its SDK licenses into existing applications maintained by its customers, as well as custom application development and support services; and provision of cloud-based vertical solutions for healthcare, retail, sports, aviation, real estate, hospitality, education, and other applications, as well as application transactions, including re-occurring and one-time transactional media purchases for application discovery, user acquisition and audience building, audience engagement, and audience monetization. Phunware, Inc. was founded in 2009 and is headquartered in Austin, Texas.

Radcom NASDAQ:RDCM

$9.91 -0.05 (-0.50%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$9.92 +0.01 (+0.06%)

As of 09/11/2026 07:30 PM Eastern

RADCOM Ltd. provides 5G ready cloud-native, network intelligence, and service assurance solutions for telecom operators or communication service providers (CSPs). It offers RADCOM ACE, including RADCOM Service Assurance, a cloud-native, 5G-ready, and virtualized service assurance solutions, which allows telecom operators to gain end-to-end network visibility and customer experience insights across all networks; RADCOM Network Visibility, a cloud-native network packet broker and filtering solution that allows CSPs to manage network traffic at scale across multiple cloud environments, and control the visibility layer to perform analysis of select datasets; and RADCOM Network Insights, a business intelligence solution that offers insights for multiple use cases enabled by data captured and correlated through RADCOM Network Visibility and RADCOM Service Assurance. The company also provides solutions for mobile and fixed networks, such as 5G, long term evolution (LTE), voice over LTE, voice over Wifi, IP multimedia subsystem, voice over IP, and universal mobile telecommunication service. It sells its products directly to customers through executives and sales representatives, as well as through a network of distributors and resellers in North America, Asia Pacific, Latin America, Europe, the Middle East, Africa, and Israel. The company was formerly known as Big Blue Catalogue Ltd. and changed its name to RADCOM Ltd. in 1989. RADCOM Ltd. was incorporated in 1985 and is headquartered in Tel Aviv, Israel.

Coeptis Therapeutics NASDAQ:ZSQR

$3.07 -0.09 (-2.85%)

As of 09/11/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHUN, RDCM, ZSQR, and EGAN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHUN, RDCM, ZSQR, and EGAN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHUN, RDCM, ZSQR, and EGAN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHUN, RDCM, ZSQR, and EGAN Company Descriptions

eGain NASDAQ:EGAN

Phunware NASDAQ:PHUN

Radcom NASDAQ:RDCM

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PHUN, RDCM, ZSQR, and EGAN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PHUN, RDCM, ZSQR, and EGAN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PHUN, RDCM, ZSQR, and EGAN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHUN, RDCM, ZSQR, and EGAN Company Descriptions

eGain NASDAQ:EGAN

Phunware NASDAQ:PHUN

Radcom NASDAQ:RDCM

Coeptis Therapeutics NASDAQ:ZSQR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools